Cellectis S.A. (CLLS) stock forecast and price target
Price $1.18 · data as of November 13, 2026
12-month price target
Average target$4.45
Upside / downside+277.1%
Analysts4
ConsensusBuy
Low $1.30Average $4.45High $8.00
Gold marker: average target · white marker: today’s price ($1.18)
Analyst ratings
Strong buy 0Buy 2Hold 2Sell 0Strong sell 1
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-1.25 | −104.9% | $29M |
| Next fiscal year ends December 31, 2027 | $-0.55 | +56.0% | $36M |
| Next quarter ends December 31, 2026 | $-0.22 | +8.3% | $8M |
| Quarter after ends March 31, 2027 | $-0.19 | — | $23M |
Consensus of the analysts covering Cellectis, updated daily. In the last 30 days 1 estimates were raised and 0 lowered.
Frequently asked questions
What is the Cellectis stock price target?
The average 12-month target from 4 analysts is $4.45, 277.1% above the current price of $1.18 Targets range from $1.30 to $8.00.
Is Cellectis a buy according to analysts?
The consensus rating is “Buy” (2 buy, 2 hold, 1 strong sell). Ratings are opinions, not guarantees; this is not investment advice.
How much is Cellectis expected to earn?
Analysts expect EPS of $-1.25 for the fiscal year ending December 31, 2026 and $-0.55 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.